Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼

Saturday, June 12, 2010

Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: A meta-analysis

CONCLUSIONS: OC users carrying an ascertained BRCA1/2 mutation have a reduced risk of ovarian cancer, proportional to the duration of use. There is no evidence that recent OC formulations increase breast cancer risk in carriers

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.